British pharma giant AstraZeneca to invest $2.5 billion in new China hub

British pharma giant AstraZeneca to invest .5 billion in new China hub

Outside the Macclesfield factory of AstraZeneca.

Christopher Furlong | Getty Images News | Getty Images

British pharmaceutical giant AstraZeneca on Friday said that it will invest $2.5 billion in a research and development center in Chinese capital Beijing.

The new hub is expected to take AstraZeneca’s Beijing workforce to around 1,700 employees.

Don’t miss AstraZeneca’s CEO Pascal Soriot interview live on CNBC International at 11:30 a.m. London time / 7:30 a.m. ET.

This breaking news story is being updated.

Source

Health

How twin sister triathletes doubled down on sports success to raise health-startup millions from investors

June 5, 2025

During their last year of completing work for doctoral degrees in physiology, twin sisters Michal Mor and Merav Mor started to compete in Ironman triathlon races. The demand for peak fitness led them to the realize the importance of understanding personal metabolism, and the lack of data being collected on it through devices accessible to […]

Health

It’s not just AI — China’s quickly gaining an edge over the U.S. in biotech

June 5, 2025

Two graduate students research chemical products in a laboratory in Xiwangzhuang Town, Zaozhuang City, Shandong province of China, on Dec. 26, 2023. Nurphoto | Nurphoto | Getty Images BEIJING — For all the attention on U.S.-China competition in artificial intelligence, new studies point to China’s rapid rise in biotechnology, especially for drug and agricultural development. […]

Health

Healthy Returns: AstraZeneca, Pfizer, Gilead and other drugmakers release promising cancer drug data at ASCO

June 3, 2025

Attendees walk through the lobby at the American Society of Clinical Oncology annual meeting in Chicago. Tim Boyle | Bloomberg | Getty Images A version of this article first appeared in CNBC’s Healthy Returns newsletter, which brings the latest health-care news straight to your inbox. Subscribe here to receive future editions. I’m back in New […]